New balloon could offer alternative for clogged arteries

NCT ID NCT06822712

Recruiting now Disease control Sponsor: BrosMed Medical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compares a new balloon coated with sirolimus to an existing balloon coated with paclitaxel for treating blocked heart arteries. About 250 adults with coronary artery disease will be randomly assigned to receive one of the two balloons during a procedure to open their arteries. The main goal is to see if the sirolimus balloon works as well as the paclitaxel balloon in keeping arteries open after 9 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sirolimus-coated balloon catheter
What this could lead to: If it works, this could offer a new treatment option for blocked heart arteries that may be as effective as current options.
What could go wrong: This is a noninferiority trial, meaning it aims to show the new balloon is not worse than the existing one, not that it is better. The study is still recruiting and results are not yet available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERIAL DISEASE (CAD)

Contacts and locations

Locations

The First Hospital of Lanzhou University
RECRUITING

Lanzhou, Gansu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.